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ABSTRACT
Background Low socioeconomic position (SEP) and 
family history of type 2 diabetes mellitus (T2DM) contribute 
to increased T2DM risk, but it is unclear whether they 
exacerbate each other’s effect. This study examined 
whether SEP reinforces the association of T2DM family 
history with T2DM, and whether behavioural and clinical 
risk factors can explain this reinforcement.
Methods We used cross-sectional data on 51 725 
participants from Lifelines. SEP was measured as 
educational level and was self-reported, just as family history 
of T2DM. T2DM was diagnosed based on measured fasting 
plasma glucose and glycated haemoglobin, combined with 
self-reported disease and recorded medication use. We 
assessed interaction on the additive scale by calculating the 
relative excess risk due to interaction (RERI).
Results ORs of T2DM were highest for males (4.37; 95% 
CI 3.47 to 5.51) and females (7.77; 5.71 to 10.56) with 
the combination of low SEP and a family history of T2DM. 
The RERIs of low SEP and a family history of T2DM were 
0.64 (−0.33 to 1.62) for males and 3.07 (1.53 to 4.60) 
for females. Adjustment for behavioural and clinical risk 
factors attenuated associations and interactions, but risks 
remained increased.
Conclusion Low SEP and family history of T2DM are 
associated with T2DM, but they also exacerbate each 
other’s impact in females but not in males. Behavioural 
and clinical risk factors partly explain these gender 
differences, as well as the associations underlying the 
interaction in females. The exacerbation by low SEP 
of T2DM risks in T2DM families deserves attention in 
prevention and community care.
INTRODUCTION
Type 2 diabetes mellitus (T2DM) is a common 
chronic health condition with an estimated 
prevalence of 9.8% in males and 9.2% in 
females.1 2 Globally, the number of people with 
T2DM has increased during the past decades 
from 153 million in 1980 to 347 million in 
2008 and is estimated to rise to 439 million 
in 2030.1 2 Moreover, between 1990 and 2010, 
T2DM was the non-communicable disease 
with the fastest increasing contribution to the 
burden of lost disability adjusted life years 
(DALYs).3 To tackle this major public health 
challenge, a better understanding of the 
interplay between modifiable and non-mod-
ifiable risk factors is needed.
Both low socioeconomic position (SEP) 
and family history of T2DM contribute to the 
increased risk of T2DM,4–13 but little is known 
about the impact of their co-occurrence. 
Interaction between low SEP and family 
history of T2DM may be likely because adverse 
circumstances related to a low SEP, like the 
co-occurrence of adverse health behaviours 
and clinical risk factors,14 15 may aggravate 
the familial predisposition for T2DM through 
the interplay of environment and genetics.16 
Low SEP has been associated with a higher 
risk for T2DM in many studies.4–8 Poor health 
behaviours and clinical risk factors, such as 
obesity, partly explain this higher risk.4–7 17 18 
Family history of T2DM has also consistently 
been associated with an increased risk for 
T2DM and is one of the most important 
factors predicting the disease.9–13 However, 
their co-occurrence seems to have escaped 
attention, despite its large potential impact.
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Strengths and limitations of this study
 ► This study examines the likely but largely 
unexamined biological interaction between 
socioeconomic position and family history of type 2 
diabetes mellitus (T2DM) on T2DM occurrence.
 ► Objective measures of fasting plasma glucose, 
glycated haemoglobin and clinical risk factors for 
T2DM were obtained from 51 725 participants.
 ► Results are based on a population-based study 
sample and generalisable to the general population.
 ► The cross-sectional study design does not allow for 
conclusions about causality, pointing to the need for 
longitudinal studies.
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The impact of their co-occurrence in particular regards 
biological interaction, that is, two or more causes of disease 
that together assert their influence on disease risk.19 This 
interaction between low SEP and family history of T2DM 
may have large consequences for prevention and clinical 
care. For example, improved detection methods and a 
better tailoring of interventions to individual character-
istics may help to decrease disease related morbidity and 
mortality.3 20 The possible aggravation of familial predis-
position for T2DM by low SEP may differ between males 
and females through fundamental biological gender 
differences in genes and hormones in the development 
of T2DM.21 For example, some aspects of the control of 
metabolic homeostasis are regulated differently in males 
and females.21 Gender differences in the aggravation 
of familial predisposition for T2DM by low SEP may be 
important for the development of prevention and inter-
vention programs and therefore need to be taken into 
account.
In the current study we examined the associations of 
SEP, family history of T2DM and their interaction on the 
occurrence of T2DM and whether these associations and 
interactions can be explained by behavioural and clinical 
risk factors.
METHODS
Study design and sample
The study sample was derived from the Lifelines Cohort 
Study.22 Lifelines is a multi-disciplinary prospective popu-
lation-based Cohort study of 167 729 persons living in the 
North of The Netherlands. Participants were recruited 
from November 2006 to December 2013 through their 
general practitioner or participating family members. 
Additionally, there was the option to self-register. The 
recruitment and collection of data have been described 
in detail elsewhere.22 Lifelines was conducted according 
to the guidelines in the Declaration of Helsinki, and all 
procedures involving human subjects were approved 
by the Medical Ethics Committee of the University 
Medical Center Groningen. Written informed consent 
was obtained from all participants during the visit at the 
research centre.
The current study uses data from participants who 
visited the Lifelines research centres between July 2012 
and December 2013 for the baseline measurement 
(n=52 746), because family history of T2DM was only 
assessed during this period. A total of 51 725 participants 
(98.1% of the 52 746 possible participants) were included 
in the analysis after excluding 1021 participants with 
missing data on SEP.
Measures and procedures
Type 2 diabetes mellitus
Participants were categorised as having T2DM if they had 
a measured fasting plasma glucose (FPG) ≥7.0 mmol/L,23 
and/or a measured glycated haemoglobin (HbA1c)≥6.5% 
(48 mmol/mol),23 and/or self-reported T2DM (ie, ‘Do 
you have diabetes mellitus?’, ‘If you have diabetes, what 
type of diabetes do you have?' With answer categories: 
type 1, type 2, other, I do not know) in combination 
with self-reported medication use (ie, only tablets, only 
insulin, tablets and insulin, only a diet) and/or recorded 
T2DM medication use (ie, anatomical therapeutic chem-
ical (ATC) codes A10A and A10B).24 The classification of 
T2DM diagnosis was made by a group of experts and was 
also used in previous studies that used Lifelines data.25 26
Family history of T2DM
Family history of T2DM was assessed using the following 
question: ‘Do your parents, siblings or children have 
T2DM, or have they had T2DM?’ with answer categories 
‘yes, my father’, ‘yes, my mother’, ‘yes, my brother(s) 
and/or sister(s)’, ‘yes, my child(ren)’ and ‘no’. Partici-
pants reporting having a first-degree relative (ie, parent, 
sibling or child) with T2DM were categorised as having a 
family history of T2DM.
Socioeconomic position
SEP was defined by educational level. Educational level 
was measured according to the International Standard 
Classification of Education with a single-item question 
regarding the highest educational level achieved.27 SEP 
was categorised into low (no education, primary educa-
tion, lower or preparatory vocational education, lower 
general secondary education), medium (intermediate 
vocational education or apprenticeship, higher general 
senior secondary education or pre-university secondary 
education) and high (higher vocational education, 
university).
Health-related behaviour
Health-related behaviour concerned smoking status, 
alcohol consumption and physical activity. Smoking status 
was categorised as participants being a current smoker, 
former smoker or non-smoker.28 Alcohol consumption 
was categorised as participants being a non-drinker (0 
drinks/day), light drinker (≤1 drink/day), moderate 
drinker (>1 to 2 drinks/day) or heavy drinker (>2 drinks/
day).28 Physical activity was categorised as participants 
being inactive (0–2 days per week active for ≥30 min), 
moderately active (3–4 days per week active for ≥30 min) 
or active (≥5 day per week active for ≥30 min).
Clinical risk factors
Clinical risk factors concerned body mass index (BMI), 
waist circumference (WC) and hypertension. BMI was 
calculated as weight (kg) divided by height (m) squared 
and used as an index of general weight status. Participants 
were categorised as underweight (BMI <18.5), normal 
weight (BMI ≥18.5 −≤24.9), overweight (BMI ≥25.0 −≤29.9) 
or obese (BMI ≥30.0).29 WC was measured to the nearest 
0.5 cm and used as an index of abdominal obesity. WC 
was categorised into no abdominal obesity (WC <102 cm 
in males, WC <88 cm in females) and abdominal obesity 
(WC ≥102 cm in males, WC ≥88 cm in females).29 Hyperten-
sion diagnosis was based on measured blood pressure and 
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recorded medication use. Participants with a measured 
BP >140/90 mm Hg30 and participants with recorded anti-
hypertensive medication (ie, ATC codes C02, C03, C07, 
C08, C09)24 were categorised as hypertensive. Hyperten-
sion diagnosis was made by a group of experts and was 
also used in previous studies that used Lifelines data.25 26 
All physical measurements were performed by trained 
research staff using standardised protocols and calibrated 
equipment.22
Statistical analyses
First, we described baseline characteristics concerning 
socio-demographic, behavioural and clinical risk factors 
using descriptive statistics.
Second, we assessed associations of SEP and family 
history of T2DM on T2DM using logistic regression 
models. Potential modification of gender was assessed 
by adding an interaction term to the model. As signif-
icant modification was found (p=0.001), all analyses 
were stratified by gender. ORs with 95% CIs were 
presented for each combination of SEP and family 
history of T2DM with the category of high SEP and no 
family history of T2DM serving as a reference category.31 
These and following analyses were adjusted for age and 
age-squared. The age-squared term was added because 
the logit of the risk for T2DM may have a non-linear 
association with age.
Third, we measured interaction of SEP and family 
history of T2DM on the additive scale because the addi-
tive model best fits the method for assessing biological 
interaction.19 31 32 To examine this interaction, multi-
nomial logistic regression analyses were performed to 
obtain regression coefficients and the asymptotic cova-
riance matrix. The recommended syntax by Andersson 
et al33 was used for these analyses. The model was spec-
ified as i=1 when low SEP was present and 0 when high 
SEP was present, and j=1 when family history of T2DM 
was present and 0 when family hstory of T2DM was not 
present. Participants with a medium SEP were thus not 
included in these analyses (ie, for them, separate analyses 
were performed). ORij was the OR in exposure category 
i.j. Three ORs (ie, OR11, OR10 and OR01), with OR00 as the 
reference category, were estimated. The relative excess 
risk due to interaction (RERI) was calculated with the 
formula RERI=OR11−OR10−OR01+1 using the regression 
coefficients and covariance matrix obtained from the 
multinomial logistic regression analysis.33 The 95% CI for 
the RERI was calculated with the delta method using the 
algorithm by Andersson et al.33 34 Interaction was present 
when the 95% CI did not include 0. All analyses were 
repeated with medium SEP as risk factor (ie, comparing 
medium with high SEP, with medium SEP coded as 1 and 
high SEP as 0).
Fourth, as suggested by Knol and VanderWeele31 we 
also examined the associations of SEP and T2DM in cate-
gories of T2DM family history (ie, yes and no) and the 
associations of family history of T2DM and T2DM in cate-
gories of SEP (low, medium and high). These analyses 
offer additional information on the nature of the inter-
action effects.
Fifth, to examine whether behavioural and clinical risk 
factors explain the associations and interactions of SEP 
and T2DM family history with T2DM, we adjusted the 
basic model including age and age-squared stepwise for 
behavioural and clinical risk factors, including smoking 
status, alcohol consumption and physical activity (model 
1), and further for general weight status and abdom-
inal obesity (model 2) and finally also for hypertension 
(model 3). Participants with missing data on behavioural 
or clinical risk factors were omitted from the analyses. In 
the final model we had 12.8% missing data, mainly due to 
missing data on alcohol use (4.0%), smoking (8.0%) and 
physical activity (6.2%), with for some participants having 
missing data on several behaviours. Data on clinical risk 
factors were mostly complete (ie, only 21 (0.0%) missing 
values).
In sensitivity analyses, we examined whether the results 
were consistent if we based family history on parental 
T2DM only (ie, siblings and children not included in 
family history). We also repeated the analyses for maternal 
and paternal T2DM separately.
RESULTS
Baseline characteristics of the study population are shown 
in table 1. The proportion of participants with general 
obesity was three times higher in those with low SEP and 
a family history of T2DM (26.3%) than in those with high 
SEP without a family history of T2DM (8.9%). T2DM was 
most prevalent in males (figure 1), with an OR, corrected 
for age and age-squared, of 1.44 (95% CI 1.31 to 1.58) 
compared with females. Across categories of SEP and 
family history of T2DM, the prevalence of T2DM was 
highest for those with a low SEP in combination with 
a family history of T2DM (12.8% for males; 10.7% for 
females).
The associations and interactions of SEP and T2DM 
family history with T2DM are shown in table 2. The OR 
for T2DM was highest for females with low SEP and 
a family history of T2DM (OR: 7.77; 95% CI: 5.71 to 
10.56). A significant interaction between low SEP and a 
family history of T2DM was observed in females (RERI: 
3.07; 95% CI: 1.53 to 4.60) but not in males (RERI: 0.64; 
95% CI: −0.33 to 1.62). A similar gender difference in 
interactions was observed for medium SEP.
The underlying gender-specific ORs confirm this gender 
difference in interactions if looking per category of T2DM 
family history and per category of SEP (table 3). In general, 
the socioeconomic gradient in ORs for T2DM was steeper 
for females than for males, both for those with and without 
a family history of T2DM. Females without a family history 
of T2DM had a higher OR for low SEP (OR: 2.41; 95% CI: 
1.75 to 3.32) than males (OR: 1.39; 95% CI: 1.11 to 1.76), 
while the OR for medium SEP was similar. Females with a 
family history of T2DM had higher ORs for medium and low 
SEP compared with their male counterparts. Furthermore, 
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females with medium SEP had a higher OR for having a 
family history of T2DM than their male counterparts, while 
ORs were similar for high and low SEP.
Behavioural and clinical risk factors partly explained 
the associations and interactions of SEP and family 
history of T2DM with T2DM for males and females 
(table 4). In particular weight status in females 
appeared important for the increased OR for T2DM 
in low-SEP participants. The OR decreased from 6.01 
to 4.09 after correction for general weight status 
and abdominal obesity. Interaction in females was 
still observed after adjustment for age, age-squared, 
smoking status, alcohol consumption and physical 
activity (RERI: 1.92; 95% CI 0.54 to 3.30), and after 
additional adjustment for weight status (RERI: 1.05; 
95% CI 0.02 to 2.09). However, the interaction was 
no longer statistically significant after additional 
adjustment for hypertension (RERI: 0.88; 95% CI 
Table 1 Baseline characteristics by SEP and family history of T2DM





















Age, years (mean, SD) 42.0 (12.7) 47.6 (11.5) 39.9 (12.9) 46.4 (10.7) 49.1 (14.4) 53.1 (11.5)
Gender (% F) 56.4 56.3 58.2 63.8 55.6 61.6
Smoking (%)
Current smoker 11.4 11.8 20.0 17.9 23.9 21.1
Former smoker 28.7 35.0 28.4 34.3 37.2 40.3
Non-smoker 59.9 53.2 51.7 47.8 38.9 38.6
Alcohol (%)
Non-drinker 11.8 14.5 16.6 20.7 21.4 25.4
Light drinker 55.8 54.2 54.5 53.7 48.4 47.6
Moderate drinker 24.4 24.4 20.3 18.7 19.9 19.1
Heavy drinker 8.1 6.9 8.6 6.9 10.3 7.8
Physical activity (%)
Inactive 23.9 24.1 28.5 28.1 29.6 29.2
Moderately active 28.5 25.7 25.4 25.6 24.5 23.5
Active 47.6 50.2 46.1 46.3 46.0 47.3
BMI (mean, SD) 24.9 (3.8) 26.1 (4.2) 25.6 (4.2) 27.1 (4.7) 26.6 (4.5) 27.7 (4.7)
General weight status 
(%)
Underweight 0.9 0.6 1.1 0.5 0.9 0.3
Normal weight 56.3 43.9 48.7 34.4 37.4 29.0
Overweight 33.9 39.9 37.2 42.4 42.6 44.3
Obese 8.9 15.7 13.0 22.7 19.1 26.3
WC, cm F (mean, SD) 82.3 (10.8) 86.2 (11.9) 84.4 (12.0) 89.7 (13.0) 88.3 (12.6) 92.2 (13.0)
WC, cm M (mean, SD) 92.2 (10.1) 95.5 (10.0) 93.0 (10.8) 97.4 (10.9) 96.6 (11.4) 99.8 (11.2)
Abdominal obesity 
(%)
21.9 34.1 28.3 44.2 41.0 52.4
T2DM (%) 1.4 5.6 1.4 6.4 3.6 11.5
Systolic blood 
pressure, mm Hg 
(mean, SD)
122.1 (14.7) 125.2 (15.5) 123.3 (14.1) 126.1 (15.1) 128.3 (15.9) 130.3 (16.1)
Diastolic blood 
pressure, mm Hg 
(mean, SD)
72.4 (9.3) 74.4 (9.7) 72.4 (9.3) 74.3 (9.4) 74.8 (9.7) 75.5 (9.6)
Hypertension (%) 16.8 26.4 18.0 28.0 32.7 41.8
 BMI, body mass index; SEP, socioeconomic position; T2DM, type 2 diabetes mellitus; WC, waist circumference.
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−0.09 to 1.85). Findings were almost similar for the 
interaction between medium SEP and family history 
of T2DM, but the RERI remained statistically signif-
icant after additional adjustment for hypertension.
Sensitivity analyses showed that the main findings 
remain consistent when using different categorisations 
for family history (table 5). The first part of table 5 shows 
the results of repeating the main analyses with family 
history based only on parental T2DM (ie, siblings and 
children not included in family history). Except for a 
small difference in the magnitude of associations and 
interactions, results were virtually identical to the main 
analyses. The second part of table 5 shows that findings 
are also essentially similar when repeating the analyses for 
maternal and paternal T2DM separately.
DISCUSSION
Our study shows that low SEP and family history of T2DM 
are separately associated with the occurrence of T2DM 
Figure 1 Prevalence of T2DM for males and females per socioeconomic category, by family history of T2DM. 
Table 2 Associations and interactions of SEP and T2DM family history with T2DM, stratified by gender
Males Females
n T2DM/n total OR (95% CI) RERI (95% CI) n T2DM/n total OR (95% CI) RERI (95% CI)
No family history of 
T2DM
High SEP 130/5835 1.00 (ref) 52/7551 1.00 (ref)
Medium SEP 153/6843 1.28 (1.01 to 
1.63)
82/9524 1.33 (0.94 to 
1.89)
Low SEP 188/4607 1.39 (1.10 to 
1.75)
188/5769 2.45 (1.79 to 
3.37)
Family history of T2DM
High SEP 109/1236 3.34 (2.55 to 
4.37)
49/1594 3.24 (2.18 to 
4.82)
Medium SEP 135/1604 3.72 (2.89 to 
4.80)
0.41 (−0.46 to 
1.29)∗
147/2822 6.02 (4.36 to 
8.32)
2.77 (1.48 to 
4.06)∗
Low SEP 213/1668 4.37 (3.47 to 
5.51)
0.64 (−0.33 to 
1.62)†
286/2672 7.77 (5.71 to 
10.56)
3.07 (1.53 to 
4.60)†
ORs are adjusted for age and age-squared.
*RERI T2DM for medium SEP.
†RERI T2DM for low SEP.
RERI, relative excess risk due to interaction; SEP, socioeconomic position; T2DM, type 2 diabetes mellitus.
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and, more importantly, exacerbate each other’s impact 
in females but not in males although at generally lower 
absolute rates in females than in males. The same gender 
difference in interaction was found for medium SEP, but 
to a lesser degree. Behavioural and clinical risk factors, 
especially weight status, partly explained these gender 
differences, as well as the associations underlying the 
interaction between low SEP and family history of T2DM 
in females.
We found that the combination of low SEP and having 
a family history of T2DM had a stronger association with 
T2DM than the sum of the associations of the separate 
factors in females, but not in males. Low SEP has been 
associated with adverse health behaviours and clinical risk 
factors in many previous studies,14 15 and these factors are 
generally viewed as mediators in the relationship between 
low SEP and poor health.35 It seems likely that they aggra-
vate the genetic predisposition for T2DM through the 
complex interplay of genetics and the environment,16 
which in turn may lead to the development of T2DM. 
A possible explanation for the gender difference in this 
interaction effect may be that men and women have 
different coping styles in response to the knowledge of 
having a family history of T2DM. In general, women are 
more likely to engage in problem-focused coping styles.36 
Females with a medium or high SEP and a family history 
of T2DM may therefore make better use of the knowledge 
of having a family history of T2DM than their male coun-
terparts in adapting their preventive behaviour. However, 
the pathways leading to this gender difference definitely 
deserve further study.
Similar to previous studies,4–7 17 18 associations and 
interactions of low SEP and family history of T2DM with 
T2DM were partly explained by behavioural and clinical 
risk factors. In particular, obesity in females explained 
the increased OR/RERI for T2DM in low-SEP partici-
pants. Nevertheless, significant ORs for T2DM remained 
for both males and females with a low SEP and a family 
history of T2DM even after adjustment for all behavioural 
and clinical risk factors. Other unmeasured risk factors 
may also play a role in the development of T2DM and 
may further explain the associations and interactions. 
For example, the physiologic response to chronic stress 
exposure in low SEP individuals may increase the risk for 
T2DM and may differ by gender.37
Our finding that family history of T2DM and low SEP 
were independently associated with T2DM is consistent 
with previous cross-sectional and longitudinal studies.4–13 
A systematic review on the relation between SEP and 
T2DM incidence showed that people with low SEP have an 
Table 3 Associations of SEP with T2DM per category of T2DM family history, and associations of T2DM family history with 
T2DM per category of SEP, stratified by gender
Males Females
OR (95% CI) OR (95% CI)
The association of SEP and T2DM per category of T2DM family history
No family history of T2DM
High SEP 1 (ref) 1.00 (ref)
Medium SEP 1.27 (1.00 to 1.62) 1.33 (0.93 to 1.88)
Low SEP 1.39 (1.11 to 1.76) 2.41 (1.75 to 3.32)
Family history of T2DM
High SEP 1.00 (ref) 1.00 (ref)
Medium SEP 1.12 (0.85 to 1.47) 1.86 (1.33 to 2.59)
Low SEP 1.30 (1.01 to 1.68) 2.43 (1.76 to 3.33)
The association of T2DM family history and T2DM per category of SEP
High SEP
No family history of T2DM 1.00 (ref) 1.00 (ref)
Family history of T2DM 3.36 (2.56 to 4.42) 3.27 (2.19 to 4.90)
Medium SEP
No family history of T2DM 1.00 (ref) 1.00 (ref)
Family history of T2DM 2.93 (2.29 to 3.75) 4.52 (3.42 to 5.97)
Low SEP
No family history of T2DM 1.00 (ref) 1.00 (ref)
Family history of T2DM 3.11 (2.52 to 3.84) 3.16 (2.60 to 3.84)
ORs are adjusted for age and age-squared.
Some categories in this table are similar to those in table 2, but ORs may slightly differ because these result from within category analyses (ie, 
with a different size of the sample being analysed and therefore a slightly different correction for age and age-squared).
SEP, socioeconomic position; T2DM, type 2 diabetes mellitus.
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increased risk for T2DM, irrespective of the SEP indicator 
used.8 Although our findings might have differed some-
what for other indicators of SEP, it is likely that the main 
conclusions would be similar because all indicators for 
SEP measure a certain underlying social stratification.38 
Moreover, education has been shown to best capture the 
effects of SEP in studies on other chronic diseases in The 
Netherlands, for example, in chronic kidney disease.39 
T2DM may also affect SEP through a decrease in work 
participation, absenteeism and early retirement,40 but 
such a reverse causation is unlikely to explain our find-
ings. Our measure of SEP, educational level, has usually 
been established long before T2DM develops and is 
therefore the SEP indicator least sensitive for reverse 
causation. This is important given the cross-sectional 
nature of our study.
In the current study, predisposition for T2DM was 
defined by family history of T2DM. T2DM predispo-
sition may also be defined through a genetic risk score 
(GRS) based on risk loci obtained from genome-wide 
Table 4 Associations and interactions of SEP and T2DM family history with T2DM, stratified by gender, and adjusted for 
behavioural and clinical factors*
Male Female
OR (95% CI) RERI (95% CI) OR (95% CI) RERI (95% CI)
Model 1
No family history of 
T2DM
High SEP 1.00 1.00
Medium SEP 1.23 (0.95 to 1.59) 1.29 (0.89 to 1.87)
Low SEP 1.28 (1.00 to 1.65) 2.05 (1.46 to 2.88)
Family history of T2DM
High SEP 3.38 (2.54 to 4.51) 3.05 (1.99 to 4.68)
Medium SEP 3.67 (2.80 to 4.82) 0.12 (−0.81 to 1.05)† 5.15 (3.65 to 7.27) 1.82 (0.62 to 3.01)†
Low SEP 3.88 (3.01 to 4.98) 0.18 (−0.82 to 1.18)‡ 6.01 (4.31 to 8.37) 1.92 (0.54 to 3.30)‡
Model 2
No family history of 
T2DM
High SEP 1.00 1.00
Medium SEP 1.15 (0.88 to 1.49) 1.09 (0.75 to 1.57)
Low SEP 1.09 (0.85 to 1.41) 1.54 (1.09 to 2.17)
Family history of T2DM
High SEP 3.29 (2.46 to 4.40) 2.50 (1.62 to 3.85)
Medium SEP 3.06 (2.32 to 4.04) −0.31 (−1.16 to 0.53)† 3.70 (2.61 to 5.24) 1.04 (0.10 to 1.97)†
Low SEP 3.12 (2.41 to 4.03) −0.27 (−1.17 to 0.64)‡ 4.09 (2.92 to 5.72) 1.05 (0.02 to 2.09)‡
Model 3
No family history of 
T2DM
High SEP 1.00 1.00
Medium SEP 1.14 (0.87 to 1.48) 1.03 (0.71 to 1.49)
Low SEP 1.07 (0.83 to 1.38) 1.42 (1.01 to 2.01)
Family history of T2DM
High SEP 3.17 (2.36 to 4.25) 2.38 (1.54 to 3.68)
Medium SEP 2.98 (2.25 to 3.94) −0.25 (−1.07 to 0.56)† 3.47 (2.44 to 4.93) 0.93 (0.04 to 1.81)†
Low SEP 3.02 (2.33 to 3.91) −0.20 (−1.08 to 0.68)‡ 3.69 (2.63 to 5.18) 0.88 (−0.09 to 1.85)‡
*Adjustment regards:
Model 1: age, age-squared, smoking, alcohol consumption, physical activity.
Model 2: age, age-squared, smoking, alcohol consumption, physical activity, general weight status, abdominal obesity.
Model 3: age, age-squared, smoking, alcohol consumption, physical activity, general weight status, abdominal obesity, hypertension.
RERI, relative excess risk due to interaction; SEP, socioeconomic position; T2DM, type 2 diabetes mellitus.
†RERI T2DM for medium SEP.
‡RERI T2DM for low SEP.
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Table 5 Associations and interactions of SEP and different categorisations of T2DM family history with T2DM, stratified by 
gender
Males Females




High SEP 130/5835 1.00 (ref) 52/7551 1.00 (ref)
Medium SEP 153/6845 1.28 (1.01 to 
1.63)
82/9527 1.33 (0.94 to 
1.89)
Low SEP 188/4609 1.38 (1.10 to 
1.74)
191/5778 2.49 (1.81 to 
3.42)
Parental T2DM
High SEP 87/1123 3.15 (2.37 to 
4.20)
42/1471 3.23 (2.13 to 
4.89)
Medium SEP 120/1497 3.75 (2.89 to 
4.88)
0.32 (−0.72 to 
1.37)*
132/2,654 5.92 (4.27 to 
8.22)
2.38 (0.86 to 
3.91)*
Low SEP 177/1463 4.43 (3.48 to 
5.63)
0.88 (−0.15 to 
1.91)†
247/2372 7.93 (5.81 to 
10.81)





High SEP 131/5836 1.00 (ref) 52/7553 1.00 (ref)
Medium SEP 153/6846 1.27 (1.00 to 
1.62)
82/9530 1.33 (0.94 to 
1.89)
Low SEP 189/4612 1.38 (1.10 to 
1.74)
191/5780 2.44 (1.78 to 
3.35)
Maternal T2DM
High SEP 62/618 3.74 (2.71 to 
5.17)
24/744 3.20 (1.95 to 
5.26)
Medium SEP 87/843 4.28 (3.20 to 
5.72)
0.28 (−1.18 to 
1.74)*
90/1519 6.55 (4.61 to 
9.30)
3.00 (0.98 to 
5.02)*
Low SEP 122/922 4.39 (3.37 to 
5.72)
0.26 (−1.07 to 
1.59)†
180/1545 8.36 (6.05 to 
11.55)





High SEP 130/5835 1.00 (ref) 52/7555 1.00 (ref)
Medium SEP 153/6849 1.27 (1.00 to 
1.61)
82/9528 1.32 (0.93 to 
1.88)
Low SEP 188/4614 1.39 (1.10 to 
1.75)
191/5782 2.53 (1.84 to 
3.48)
Paternal T2DM
High SEP 40/589 3.11 (2.14 to 
4.52)
24/836 3.56 (2.17 to 
5.83)
Medium SEP 46/746 3.31 (2.32 to 
4.72)
−0.06 (−1.58 to 
1.45)*
70/1370 6.64 (4.60 to 
9.59)
2.77 (0.49 to 
5.05)*
Low SEP 74/656 4.86 (3.57 to 
6.60)
1.36 (−0.27 to 
2.99)†
104/1058 8.35 (5.90 to 
11.82)
3.28 (0.88 to 
5.68)†
ORs are adjusted for age and age-squared.
*RERI T2DM for medium SEP.
†RERI T2DM for low SEP.
RERI, relative excess risk due to interaction; SEP, socioeconomic position; T2DM, type 2 diabetes mellitus.
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association studies.41 42 Family history of T2DM captures 
both the genetic predisposition for T2DM and the shared 
environment within a family. This may on the one hand 
make family history of T2DM a better predictor of T2DM 
than a GRS, on the other hand it does not allow discrim-
ination between the effects of genes and environment. 
Although family history of T2DM and a GRS for T2DM 
both measure T2DM predisposition, future studies 
should examine if, and to what degree, the use of a GRS 
would lead to different results compared with this study. 
In addition, future studies should focus on epigenetic 
changes related to low SEP as these may play a role in 
T2DM development.43 For example, living in a deprived 
area has been related to global DNA methylation which 
in turn has been associated with inflammation markers 
and cardiovascular disease.44 Epigenetic changes related 
to low SEP might also play a role in T2DM development.
This study has a number of strengths worth mentioning. 
First, with the large sample size we could precisely esti-
mate associations and interactions of SEP and T2DM 
family history on T2DM. Second, diagnosis of T2DM was 
thoroughly assessed using self-reported disease, recorded 
medication use and, unique for the current sample size, 
objective measures of both FPG and HbA1c. Third, the 
clinical risk factors general obesity, abdominal obesity 
and hypertension were objectively measured. Finally, 
results are likely to be generalisable to the Dutch popu-
lation and those of other similar Northern European 
countries as the Lifelines study population has been 
shown to be representative for the northern part of The 
Netherlands.45
This study also has some limitations. First, the cross-sec-
tional nature of the data does not allow firm conclusions 
about causality, pointing to the need for longitudinal 
studies. Second, we could not discriminate the roles of 
genes and a shared environment, as we did not have 
genome-wide genotype data for these participants. Third, 
we categorised participants using medication with ATC 
codes A10A and A10B as having T2DM. We might have 
diagnosed participants as having T2DM while they are 
actually being treated for pre-diabetes, with metformin 
(A10B) for example. However, pharmaceutical treat-
ment of pre-diabetes is uncommon in The Netherlands. 
General practitioners are advised to use lifestyle-related 
interventions in the treatment of pre-diabetes. Fourth, we 
had some missing data on behavioural risk factors. This 
may have resulted in an under-adjustment of the associ-
ations and interactions of SEP and T2DM family history 
with T2DM.
The interaction between low SEP and family history 
of T2DM that was found in females may support early 
detection and better-tailored interventions for this 
specific group of women. Future studies need to inves-
tigate whether interventions targeted specifically at 
low-SEP females with T2DM family history contribute to 
a reduction of T2DM-related morbidity and mortality. 
Prevention and intervention strategies should include 
both individual (eg, health behaviour) and contextual 
factors (eg, food availability). Prevention and interven-
tion efforts should further take into account that people 
with a low SEP often have low health literacy.46 Low health 
literacy may hamper the translation of knowledge about 
risk factors into healthy behaviour. Future studies should 
further examine contributing pathways for the interac-
tion effect in females, as this may offer insight into which 
behavioural or clinical risk factors are most important 
to target at in this specific group of women. Despite the 
higher relative risk of T2DM for females, the absolute risk 
for T2DM was highest for males. This additionally points 
to the need for improvement of early detection and inter-
ventions in males.
We conclude that low SEP and family history of T2DM 
are independently associated with T2DM, and more 
importantly, exacerbate each other’s impact on T2DM 
in females but not in males. Behavioural and clinical risk 
factors mostly explain this interaction, but threefold risks 
remain in both males and females with low SEP in combi-
nation with a family history of T2DM. The exacerbation 
by low SEP of T2DM risks in T2DM families deserves 
attention in prevention and community care.
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